2022 annual financial data
Immunome 2022 Operating margin
Immunome 2022 operating margin with verified reported values.
Direct answer
Operating margin was -556.83%.
Operating income was -36,901,000 USD and net income was -36,896,000 USD.
Operating cash flow was -28,690,000 USD.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,627,000 USD
- Operating income
- -36,901,000 USD
- Net income
- -36,896,000 USD
- Operating cash flow
- -28,690,000 USD